BACM
CCXI

Blue Arrow Capital Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Blue Arrow Capital Management’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-124,600
Closed -$941K – 188
2015
Q1 		$941K Sell
124,600
-15,400
-11% -$120K 0.09% 129
2014
Q4 		$956K Buy
+140,000
New +$740K 0.11% 147

Other funds holding CCXI

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

Blue Arrow Capital Management's CCXI Position: Q2 2015 in Review

Blue Arrow Capital Management sold out of ChemoCentryx, Inc. (CCXI) in Q2 2015, closing a stake of 124,600 shares — an estimated $941K sold.

Blue Arrow Capital Management first reported a position in CCXI in Q4 2014 and held it in 2 quarters. The position peaked at $956K in Q4 2014. 70 funds tracked by Wall St. Rank hold CCXI as of Q2 2015.

  • Blue Arrow Capital Management reported no remaining ChemoCentryx, Inc. position as of Q2 2015 after selling out during the quarter.
  • Blue Arrow Capital Management sold 124,600 ChemoCentryx, Inc. shares in Q2 2015, an estimated $941K.
  • Blue Arrow Capital Management first reported a position in ChemoCentryx, Inc. in Q4 2014 and held it in 2 quarters.
  • Blue Arrow Capital Management's ChemoCentryx, Inc. position peaked at $956K in Q4 2014.
  • 70 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q2 2015.

Based on Blue Arrow Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.